Currently, the COVID-19 outbreak is affecting the logistics and transportation of essential commodities, including vaccines and In-vitro Diagnostics(IVDs). Recently importers approached the Central Drug and Standards Control Organization (CDSCO) and shared with the concerned office about the difficulties related to vaccines and IVDs imports. These essential imported products are stuck at the ports as samples for quality verification related to imported batches cannot be sent to the notified laboratories due to lockdown declared by the government in India.
Looking into the importance of these products for the country’s population, CDSCO released the notification for release of vaccines, IVDs and blood products (sampled 100% testing) from the ports after reviewing the documents, protocol, certificate of release batch by the manufacturer and past satisfactory history of the product. This will depend on the fulfillment of below-mentioned conditions.
CDSCO requested the port officers of the country to follow this procedure in the notification for easier availability of the essential vaccines, in vitro diagnostics, and blood products for the benefit of the country’s population. The nationwide lockdown for COVID-19 pandemic has created challenges at various levels like logistics, less manpower at each level, including the notified laboratories, however our regulatory authorities are taking important steps to make it easier and seamless for the importers and consumers.
Release of consignments of Vaccine and critical IVDs-certain instructions issued.pdf. Available at: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc4OA==.Accessed on April 05, 2020.
What a Revised Schedule M raises GMP standards in India, what has changed for manufacturers, and how large firms and MSMEs can prepare for Compliance and CDSCO inspections. Revised Schedule M is the b..
A practical comparison of CDSCO vs FDA vs EMA, explaining how each regulator’s Drug approval process differs and why one Drug needs separate approvals in India, the US and Europe. A Drug approve..
A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s..